Antifungal susceptibility of 596 Aspergillus fumigatus strains isolated from outdoor air, hospital air, and clinical samples:: Analysis by site of isolation

被引：37

作者：

Guinea, J ^{[1
]}

Peláez, T ^{[1
]}

Alcalá, L ^{[1
]}

Ruiz-Serrano, MJ ^{[1
]}

Bouza, E ^{[1
]}

机构：

[1] Univ Madrid, Microbiol Serv, Hosp Univ Gregorio Maranon, Dept Clin Microbiol & Infect Dis, Madrid 28007, Spain

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2005年 / 49卷 / 08期

关键词：

D O I：

10.1128/AAC.49.8.3495-3497.2005

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

We analyzed the activities of six antifungal drugs (amphotericin B, itraconazole, voriconazole, posaconazole, caspofungin, and micafungin) against 596 Aspergillus fumigatus strains isolated from outdoor air, hospital air, and clinical samples. We did not find differences among the susceptibilities by site of isolation.

引用

收藏

页码：3495 / 3497

页数：3

相关论文

共 15 条

[1] In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates [J].

Arikan, S ;

Lozano-Chiu, M ;

Paetznick, V ;

Rex, JH .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (01) :327-330

[2] Aspergillus fumigatus variant with decreased susceptibility to multiple antifungals [J].

Balajee, SA ;

Weaver, M ;

Imhof, A ;

Gribskov, J ;

Marr, KA .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (04) :1197-1203

[3] Aspergillus: Rising frequency of clinical isolation and continued susceptibility to antifungal agents, 1994-1999 [J].

Chandrasekar, PH ;

Cutright, JL ;

Manavathu, EK .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2001, 41 (04) :211-214

[4] In vitro susceptibility of respiratory isolates of Aspergillus species to itraconazole and amphotericin B. Acquired resistance to itraconazole [J].

Chryssanthou, E .

SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1997, 29 (05) :509-512

[5] Susceptibility testing of sequential isolates of Aspergillus fumigatus recovered from treated patients [J].

Dannaoui, E ;

Meletiadis, J ;

Tortorano, AM ;

Symoens, F ;

Nolard, N ;

Viviani, MA ;

Piens, MA ;

Lebeau, B ;

Verweij, PE ;

Grillot, R .

JOURNAL OF MEDICAL MICROBIOLOGY, 2004, 53 (02) :129-134

[6] Acquired itraconazole resistance in Aspergillus fumigatus [J].

Dannaoui, E ;

Borel, E ;

Monier, MF ;

Piens, MA ;

Picot, S ;

Persat, F .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 47 (03) :333-340

[7] Itraconazole resistance in Aspergillus fumigatus [J].

Denning, DW ;

Venkateswarlu, K ;

Oakley, KL ;

Anderson, MJ ;

Manning, NJ ;

Stevens, DA ;

Warnock, DW ;

Kelly, SL .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (06) :1364-1368

[8] Trends in the postmortem epidemiology of invasive fungal infections at a university hospital [J].

Groll, AH ;

Shah, PM ;

Mentzel, C ;

Schneider, M ;

JustNuebling, G ;

Huebner, K .

JOURNAL OF INFECTION, 1996, 33 (01) :23-32

[9] Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis [J].

Herbrecht, R ;

Denning, DW ;

Patterson, TF ;

Bennett, JE ;

Greene, RE ;

Oestmann, JW ;

Kern, WV ;

Marr, KA ;

Ribaud, P ;

Lortholary, O ;

Sylvester, R ;

Rubin, RH ;

Wingard, JR ;

Stark, P ;

Durand, C ;

Caillot, D ;

Thiel, E ;

Chandrasekar, PH ;

Hodges, MR ;

Schlamm, HT ;

Troke, PF ;

de Pauw, B .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (06) :408-415

[10] ANTIMICROBIAL SUSCEPTIBILITY TESTING OF 6 CLINICAL ISOLATES OF ASPERGILLUS [J].

KITAHARA, M ;

SETH, VK ;

MEDOFF, G ;

KOBAYASHI, GS .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1976, 9 (06) :908-914